[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-342866-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-342866-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","association-of-remote-patient-reported-outcomes-and-step-counts-with-hospitalization-or-death-among-patients-with-advanced-cancer-undergoing-chemotherapy-secondary-analysis-of-the-prostep-randomized-trial","Association of Remote Patient-Reported Outcomes and Step Counts With Hospitalization or Death Among Patients With Advanced Cancer Undergoing Chemotherapy: Secondary Analysis of the PROStep Randomized Trial","","Patients with advanced cancer receiving chemotherapy commonly develop substantial symptom burdens and worsening functional status, which correlate with adverse outcomes. Remote monitoring that combines patient-reported outcomes (PROs) with wearable step counts may help identify individuals at heightened risk for hospitalization or death. This secondary analysis evaluates longitudinal PROs with step counts, and PROs plus step counts with hospitalization or death using bootstrapped generalized linear models.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/association-of-remote-patient-reported-outcomes-and-step-counts-with-hospitalization-or-death-among-patients-with-advanced-cancer-undergoing-chemotherapy-secondary-analysis-of-the-prostep-randomized-trial/342866/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/association-of-remote-patient-reported-outcomes-and-step-counts-with-hospitalization-or-death-among-patients-with-advanced-cancer-undergoing-chemotherapy-secondary-analysis-of-the-prostep-randomized-trial/342866.png","ImageObject",300,407,{"name":42,"@type":43},"Hazel","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the study objective regarding PROs and step counts?","Question",{"text":63,"@type":64},"To assess (1) the association between longitudinal PROs and step counts, and (2) the association of PROs and step counts with hospitalization or death among patients with advanced cancer undergoing chemotherapy.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were PROs and step counts collected in the PROStep randomized trial?",{"text":68,"@type":64},"Participants were randomized to weekly text-based monitoring of 8 PROs plus continuous step-count monitoring via Fitbit versus usual care.",{"name":70,"@type":61,"acceptedAnswer":71},"What key findings relate symptom burden and step decline to hospitalization or death?",{"text":72,"@type":64},"Higher aggregate PRO scores were associated with increased odds of hospitalization or death, and decreased step counts (e.g., a 1000-step decrease) were also linked to greater odds of hospitalization or death.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},342866,1790219644,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":123,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},137441390410,"https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","JOURNAL OF MEDICAL INTERNET RESEARCH Manz et al  \nOriginal Paper  \nAssociation of Remote Patient-Reported Outcomes and Step Counts With Hospitalization or Death Among Patients With Advanced Cancer Undergoing Chemotherapy: Secondary Analysis of the PROStep Randomized Trial  \n\n| Christopher R Manz 1, MSHP, MD; Emily Schriver2,3, MS; William J Ferrell4,5, MPH; Joelle Williamson6, MPH; Jonathan Wakim6, BS; Neda Khan6,7, MHCI; Michael Kopinsky7, BSE; Mohan Balachandran7, MA, MS; Jinbo Chen5,8, PhD; Mitesh S Patel9, MBA, MD; Samuel U Takvorian5,6,10, MSHP, MD; Lawrence N Shulman5,6,10, MD; Justin EBekelman5,10, MD; Ian J Barnett8*, PhD; Ravi B Parikh2,4,5,10,11*, MPP, MD |\n| --- |\n| 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States 2Institute for Biomedical Informatics, University of Pennsylvania, Philadelphia, PA, United States\u003Cbr>3Penn Medicine Predictive Healthcare, University of Pennsylvania Health System, Philadelphia, PA, United States 4Division of Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States\u003Cbr>5Penn Center for Cancer Care Innovation, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, United States 6Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States 7Center for Health Care Innovation, Penn Medicine, Philadelphia, PA, United States\u003Cbr>8Department of Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States 9Ascension, St. Louis, MO, United States\u003Cbr>10Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, United States 11Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, United States\u003Cbr>*these authors contributed equally\u003Cbr>Corresponding Author:\u003Cbr>Ravi B Parikh, MPP, MD Division of Health Policy Perelman School of Medicine University of Pennsylvania\u003Cbr>423 Guardian Drive Room 1102 Philadelphia, PA, 19104 United States\u003Cbr>Phone: 1 3524224285\u003Cbr>[Email:](Email: Ravi.Parikh@pennmedicine.upenn.edu)[ ](Email: Ravi.Parikh@pennmedicine.upenn.edu)[Ravi.Parikh@pennmedicine.upenn.edu](Email: Ravi.Parikh@pennmedicine.upenn.edu)\u003Cbr>Abstract |\n\nBackground: Patients with advanced cancer undergoing chemotherapy experience significant symptoms and declines in functional status, which are associated with poor outcomes. Remote monitoring of patient-reported outcomes (PROs; symptoms) and step counts (functional status) may proactively identify patients at risk of hospitalization or death.  \nObjective: The aim of this study is to evaluate the association of (1) longitudinal PROs with step counts and (2) PROs and step counts with hospitalization or death.  \nMethods: The PROStep randomized trial enrolled 108 patients with advanced gastrointestinal or lung cancers undergoing cytotoxic chemotherapy at a large academic cancer center. Patients were randomized to weekly text-based monitoring of 8 PROs plus continuous step count monitoring via Fitbit (Google) versus usual care. This preplanned secondary analysis included 57 of 75 patients randomized to the intervention who had PRO and step count data. We analyzed the associations between PROs and mean daily step counts and the associations of PROs and step counts with the composite outcome of hospitalization or death using bootstrapped generalized linear models to account for longitudinal data.  \n[https://www.jmir.org/2024/1/e51059](https://www.jmir.org/2024/1/e51059)  \nXSL• FO  \nRenderX  \nJ Med Internet Res 2024 | vol. 26 | e51059 | p. 1 (page number not for citation purposes)  \nResults: Among 57 patients, the mean age was 57 (SD 10.9) years, 24 (42%) were female, 43 (75%) had advanced gastrointestinal cancer, 14 (25%) had advanced lung cancer, and 25 (44%) were hospitalized or died during follow-up. A 1-point weekly increase (on a 32-point scale) in aggregate PRO score was associated with 247 fewer mean daily steps (95% CI –277 to –213; P\u003C.001) . PRO","cbCaihFXzvj3WJ8x","https://ap.wps.com/l/cbCaihFXzvj3WJ8x","pdf",495814,"English","# Abstract\n## Background\n## Objective\n## Methods\n## Results\n## Conclusions\n## Trial Registration\n# Introduction","[{\"question\":\"What is the study objective regarding PROs and step counts?\",\"answer\":\"To assess (1) the association between longitudinal PROs and step counts, and (2) the association of PROs and step counts with hospitalization or death among patients with advanced cancer undergoing chemotherapy.\"},{\"question\":\"How were PROs and step counts collected in the PROStep randomized trial?\",\"answer\":\"Participants were randomized to weekly text-based monitoring of 8 PROs plus continuous step-count monitoring via Fitbit versus usual care.\"},{\"question\":\"What key findings relate symptom burden and step decline to hospitalization or death?\",\"answer\":\"Higher aggregate PRO scores were associated with increased odds of hospitalization or death, and decreased step counts (e.g., a 1000-step decrease) were also linked to greater odds of hospitalization or death.\"}]","Association of Remote Patient-Reported Outcomes and Step Counts With Hospitalization or Death Among Patients With Advanced Cancer Undergoing Chemotherapy: Secondary Analysis of the PROStep Randomized Trial | PDF",1790048468,25,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/18cdcea76c7bfb224affa91e016984f1.webp",983,1390,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8b2a79036237d4e9bdfdd9ffa7c178b7.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2bd8322e0687665057c4f3bcfebfde21.webp",981,1387,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/efa14aef2b05145042c865d5d0a8f3a5.webp",980,1385]